Reply to ‘Comment on ‘Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy’’
Crossref DOI link: https://doi.org/10.1038/bjc.2017.61
Published Online: 2017-03-14
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fujii, Takeo
Ueno, Naoto T
Text and Data Mining valid from 2017-03-14
Article History
First Online: 14 March 2017
Competing interests
: The authors declare no conflict of interest.